(SLB, BIOD, INSM) CRWENewswire Stocks In Action
- 2012/01/21 03:43:45 投稿
- 再生数：21
- マイリスト数：0
Insmed Inc - INSM - reported that the FDA has lifted the clinical hold previously placed on ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacteria lung disease. Schlumberger Ltd - SLB - posted full-year 2011 revenue of $39.54 billion versus $27.45 billion in 2010.